NexImmune, Inc. (NEXI)

USD 0.0

(0.0%)

Inventory Summary of NexImmune, Inc.

  • NexImmune, Inc.'s latest annual inventory in 2023 was - USD , up 100.0% from previous year.
  • NexImmune, Inc.'s latest quarterly inventory in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • NexImmune, Inc. reported annual inventory of -19.46 Thousand USD in 2022, down 0.0% from previous year.
  • NexImmune, Inc. reported annual inventory of - USD in 2021, down 0.0% from previous year.
  • NexImmune, Inc. reported quarterly inventory of - USD for 2024 Q1, down 0.0% from previous quarter.
  • NexImmune, Inc. reported quarterly inventory of - USD for 2023 Q4, up 100.0% from previous quarter.

Annual Inventory Chart of NexImmune, Inc. (2023 - 2018)

Historical Annual Inventory of NexImmune, Inc. (2023 - 2018)

Year Inventory Inventory Growth
2023 - USD 100.0%
2022 -19.46 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 61.07 Thousand USD 0.0%
2018 - USD 0.0%

Peer Inventory Comparison of NexImmune, Inc.

Name Inventory Inventory Difference
America Great Health 108.35 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. 1.00 USD 100.0%
Aridis Pharmaceuticals, Inc. - USD NaN%
Biora Therapeutics, Inc. - USD NaN%
Bio-Path Holdings, Inc. 632.00 USD 100.0%
Better Therapeutics, Inc. - USD NaN%
Calithera Biosciences, Inc. - USD NaN%
Comera Life Sciences Holdings, Inc. 2.5 Million USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
eFFECTOR Therapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. - USD NaN%
Evelo Biosciences, Inc. - USD NaN%
Evolutionary Genomics, Inc. - USD NaN%
Finch Therapeutics Group, Inc. - USD NaN%
Galera Therapeutics, Inc. - USD NaN%
Innovation1 Biotech Inc. - USD NaN%
Kiromic BioPharma, Inc. - USD NaN%
Molecular Templates, Inc. - USD NaN%
Navidea Biopharmaceuticals, Inc. 427.34 Thousand USD 100.0%
Orgenesis Inc. 34 Thousand USD 100.0%
Panbela Therapeutics, Inc. - USD NaN%
Point of Care Nano-Technology, Inc. - USD NaN%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 9.97 Million USD 100.0%
Statera Biopharma, Inc. 1.8 Million USD 100.0%
TRACON Pharmaceuticals, Inc. - USD NaN%
Trevena, Inc. - USD NaN%
Vaxxinity, Inc. - USD NaN%
Vaccinex, Inc. - USD NaN%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. - USD NaN%
ZIVO Bioscience, Inc. - USD NaN%